Pharma’s Cutting Edge » Torcetrapib setback

    <p class=default>
      
        09:39 PM, November 15, 2006
      
    </p>

<p>

      
        Nov 2 2006 ...  Pfizer has prev. indicated that FDA would finish its review of the pivotal 
        IVUS intravascular ultrsono trial in which Pfizer hopes to
      
    <br/>

      
        show plaque diamewter reduction with the drug by end of 2008.
      
    <br/>

      
        BUT FDA may require a clinical outcomes study before FDA approval, which won't be 
        available til 2010.
      
    </p>